Glenmark Life Sciences Limited (GLS.BO)
INR 1085.8
(0.0%)
INR 1085.8
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 6.86 Billion INR | 2.16% |
| 2022 | 6.71 Billion INR | 6.38% |
| 2021 | 6.3 Billion INR | 6.59% |
| 2020 | 5.91 Billion INR | 22.11% |
| 2019 | 4.83 Billion INR | 12.71% |
| 2018 | 2.48 Billion INR | 3311330.77% |
| 2017 | 10 Thousand INR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 1.42 Billion INR | -13.39% |
| 2024 Q1 | 1.59 Billion INR | 14.11% |
| 2023 Q1 | 1.95 Billion INR | -6.81% |
| 2023 FY | - INR | 2.16% |
| 2023 Q3 | 1.74 Billion INR | 1.04% |
| 2023 Q2 | 1.72 Billion INR | -11.57% |
| 2023 Q4 | 1.44 Billion INR | -17.03% |
| 2022 Q1 | 1.56 Billion INR | 6.08% |
| 2022 FY | - INR | 6.38% |
| 2022 Q4 | 2.09 Billion INR | 37.62% |
| 2022 Q3 | 1.52 Billion INR | -1.04% |
| 2022 Q2 | 1.53 Billion INR | -1.67% |
| 2021 Q1 | 1.64 Billion INR | -3.4% |
| 2021 Q2 | 1.69 Billion INR | 3.04% |
| 2021 Q3 | 1.49 Billion INR | -11.7% |
| 2021 Q4 | 1.47 Billion INR | -1.53% |
| 2021 FY | - INR | 6.59% |
| 2020 FY | - INR | 22.11% |
| 2020 Q4 | 1.7 Billion INR | 9.68% |
| 2020 Q3 | 1.55 Billion INR | 22.27% |
| 2020 Q2 | 1.26 Billion INR | -7.12% |
| 2020 Q1 | 1.36 Billion INR | 0.0% |
| 2019 FY | - INR | 12.71% |
| 2018 FY | - INR | 3311330.77% |
| 2017 FY | - INR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 9.61 Billion INR | 28.636% |
| Aurobindo Pharma Limited | 61.78 Billion INR | 88.893% |
| Granules India Limited | 8.6 Billion INR | 20.235% |
| Indoco Remedies Limited | 2.64 Billion INR | -159.265% |
| Achyut Healthcare Limited | 524 Thousand INR | -1309609.924% |
| Ajanta Pharma Limited | 12.56 Billion INR | 45.383% |
| Alkem Laboratories Limited | 24.19 Billion INR | 71.635% |
| Alpa Laboratories Limited | 86.12 Million INR | -7868.326% |
| Brooks Laboratories Limited | 41.72 Million INR | -16346.702% |
| AstraZeneca Pharma India Limited | 2.35 Billion INR | -191.195% |
| Bajaj HealthCare Limited | 444.51 Million INR | -1443.899% |
| Bliss GVS Pharma Limited | 1.47 Billion INR | -364.012% |
| Dr. Reddy's Laboratories Limited | 88.27 Billion INR | 92.226% |
| Eris Lifesciences Limited | 6.98 Billion INR | 1.769% |
| FDC Limited | 4.4 Billion INR | -55.915% |
| Glenmark Pharmaceuticals Limited | 11.34 Billion INR | 39.501% |
| Gufic Biosciences Limited | 1.48 Billion INR | -363.556% |
| Ind-Swift Laboratories Limited | 6.86 Billion INR | -0.018% |
| Ipca Laboratories Limited | 13.29 Billion INR | 48.397% |
| Jagsonpal Pharmaceuticals Limited | 323.46 Million INR | -2021.709% |
| Krebs Biochemicals & Industries Limited | -82.72 Million INR | 8395.816% |
| Lasa Supergenerics Limited | -65.08 Million INR | 10645.298% |
| Laurus Labs Limited | 8 Billion INR | 14.278% |
| Lupin Limited | 36.96 Billion INR | 81.436% |
| Mankind Pharma Limited | 28.09 Billion INR | 75.572% |
| Medicamen Biotech Limited | 245.66 Million INR | -2693.65% |
| Medico Remedies Limited | 150.37 Million INR | -4463.753% |
| Megasoft Limited | 284.73 Million INR | -2310.303% |
| NATCO Pharma Limited | 18.79 Billion INR | 63.486% |
| Piramal Pharma Limited | 13.05 Billion INR | 47.433% |
| RPG Life Sciences Limited | 1.28 Billion INR | -435.535% |
| Sigachi Industries Limited | 883.39 Million INR | -676.873% |
| Sun Pharmaceutical Industries Limited | 138.36 Billion INR | 95.04% |
| Suven Pharmaceuticals Limited | 4.67 Billion INR | -46.731% |
| Syncom Formulations (India) Limited | 430.27 Million INR | -1494.995% |
| Unichem Laboratories Limited | 742.35 Million INR | -824.473% |
| Wanbury Limited | 985.49 Million INR | -596.393% |
| Windlas Biotech Limited | 781.72 Million INR | -777.92% |
| ZIM Laboratories Limited | 462.09 Million INR | -1385.16% |
| Zydus Lifesciences Limited | 56.22 Billion INR | 87.793% |
| Sun Pharma Advanced Research Company Limited | -3.73 Billion INR | 283.929% |
| Divi's Laboratories Limited | 25.43 Billion INR | 73.013% |
| Hester Biosciences Limited | 539.47 Million INR | -1172.152% |
| Procter & Gamble Health Limited | 3.01 Billion INR | -127.67% |
| Amrutanjan Health Care Limited | 682.53 Million INR | -905.494% |
| Bal Pharma Limited | 345.59 Million INR | -1885.833% |
| Strides Pharma Science Limited | 3.76 Billion INR | -82.297% |
| Venus Remedies Limited | 711.8 Million INR | -864.157% |
| Aarti Pharmalabs Limited | 3.9 Billion INR | -75.547% |
| Nectar Lifesciences Limited | 1.56 Billion INR | -338.862% |
| Shilpa Medicare Limited | 2.58 Billion INR | -165.183% |
| Aarti Drugs Limited | 3.24 Billion INR | -111.255% |
| IOL Chemicals and Pharmaceuticals Limited | 2.6 Billion INR | -163.289% |
| Suven Life Sciences Limited | -992.78 Million INR | 791.279% |
| Ind-Swift Limited | 1.06 Billion INR | -544.362% |
| Valiant Laboratories Limited | 12.73 Million INR | -53772.988% |
| J. B. Chemicals & Pharmaceuticals Limited | 9.33 Billion INR | 26.481% |
| Solara Active Pharma Sciences Limited | -2.82 Billion INR | 343.201% |
| Themis Medicare Limited | 562.6 Million INR | -1119.836% |
| Hikal Limited | 2.69 Billion INR | -154.914% |
| Torrent Pharmaceuticals Limited | 35 Billion INR | 80.397% |
| Sequent Scientific Limited | 549.8 Million INR | -1148.25% |
| Novartis India Limited | 1.26 Billion INR | -440.682% |
| Wockhardt Limited | 1.08 Billion INR | -535.452% |
| Jubilant Pharmova Limited | 8 Billion INR | 14.278% |
| Biofil Chemicals and Pharmaceuticals Limited | 13.06 Million INR | -52440.805% |
| Neuland Laboratories Limited | 4.74 Billion INR | -44.537% |
| Morepen Laboratories Limited | 1.72 Billion INR | -297.628% |
| Kilitch Drugs (India) Limited | 287.42 Million INR | -2287.712% |
| Mangalam Drugs & Organics Limited | 174.94 Million INR | -3822.856% |